PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+14.73%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$352M
AUM Growth
+$352M
(+30%)
Cap. Flow
+$77.6M
Cap. Flow
% of AUM
22.07%
Top 10 Holdings %
Top 10 Hldgs %
34.86%
Holding
100
New
24
Increased
44
Reduced
21
Closed
11
Top Buys
| 1 |
Boston Scientific
BSX
|
$13.5M |
| 2 |
Eli Lilly
LLY
|
$11.4M |
| 3 |
Edwards Lifesciences
EW
|
$6.77M |
| 4 |
Haemonetics
HAE
|
$6.72M |
| 5 |
CVS Health
CVS
|
$6.11M |
Top Sells
| 1 |
Altimmune
ALT
|
$6.55M |
| 2 |
iRhythm Technologies
IRTC
|
$6.08M |
| 3 |
Avantor
AVTR
|
$5.36M |
| 4 |
908 Devices
MASS
|
$3.07M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$2.6M |
Sector Composition
| 1 | Healthcare | 96.37% |
| 2 | Industrials | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arcellx
ACLX
$3.95B
| $2.63M | 0.75% |
139,875
-38,125
| -21% | -$715K |
|
52
Axogen
AXGN
$718M
| $2.38M | 0.68% |
200,000
+11,506
| +6% | +$137K |
|
53
Alnylam Pharmaceuticals
ALNY
$58.6B
| $2.18M | 0.62% |
10,873
-9,861
| -48% | -$1.97M |
|
54
Immunic
IMUX
$79.4M
| $2.08M | 0.59% |
657,643
+7,615
| +1% | +$24.1K |
|
55
RxSight
RXST
$364M
| $2M | 0.57% |
166,761
+51,761
| +45% | +$621K |
|
56
Esperion Therapeutics
ESPR
$490M
| $1.99M | 0.56% |
+296,381
| New | +$1.99M |
|
57
Fulcrum Therapeutics
FULC
$353M
| $1.9M | 0.54% |
235,385
-27,304
| -10% | -$221K |
|
|
AKYA
58
DELISTED
Akoya BioSciences
AKYA
| $1.9M | 0.54% |
161,701
-23,084
| -12% | -$271K |
|
|
BCYC
59
Bicycle Therapeutics
BCYC
$492M
| $1.89M | 0.54% |
81,364
+20,938
| +35% | +$487K |
|
|
PHLT
60
Performant Healthcare, Inc. Common Stock
PHLT
$602M
| $1.89M | 0.54% |
1,023,350
+12,026
| +1% | +$22.2K |
|
61
Lifecore Biomedical
LFCR
$288M
| $1.8M | 0.51% |
202,248
+80,630
| +66% | +$717K |
|
62
Transmedics
TMDX
$3.65B
| $1.77M | 0.5% |
+42,358
| New | +$1.77M |
|
63
X4 Pharmaceuticals
XFOR
$70M
| $1.63M | 0.46% |
+950,000
| New | +$1.63M |
|
64
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $1.62M | 0.46% |
126,192
+1,484
| +1% | +$19.1K |
|
65
KORU Medical Systems
KRMD
$187M
| $1.52M | 0.43% |
683,466
+8,032
| +1% | +$17.9K |
|
66
Madrigal Pharmaceuticals
MDGL
$9.7B
| $1.4M | 0.4% |
21,590
+254
| +1% | +$16.5K |
|
67
Liquidia Corp
LQDA
$2.52B
| $1.38M | 0.39% |
+254,452
| New | +$1.38M |
|
68
89bio
ETNB
$1.37B
| $1.3M | 0.37% |
+225,000
| New | +$1.3M |
|
|
SLN
69
Silence Therapeutics
SLN
$237M
| $1.28M | 0.36% |
127,458
+101,208
| +386% | +$1.02M |
|
70
Veracyte
VCYT
$2.41B
| $1.01M | 0.29% |
60,883
-13,083
| -18% | -$217K |
|
71
Beyond Air
XAIR
$12.1M
| $941K | 0.27% |
+126,442
| New | +$941K |
|
72
TELA Bio
TELA
$65.4M
| $940K | 0.27% |
110,280
+1,296
| +1% | +$11K |
|
73
PepGen
PEPG
$39M
| $908K | 0.26% |
+100,000
| New | +$908K |
|
|
ISEE
74
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $897K | 0.26% |
+50,000
| New | +$897K |
|
75
Mirum Pharmaceuticals
MIRM
$3.75B
| $891K | 0.25% |
42,395
+10,381
| +32% | +$218K |
|